Assessing Whether Adma Biologics Inc (NASDAQ: ADMA) Is Over- Or Undervalued
Adma Biologics Inc (ADMA) concluded trading on Thursday at a closing price of $18.4, with 4.47 million shares of worth about $82.2 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.75% during that period and on June 26, 2025 the price saw a […]
Value Hunters: Look To Adma Biologics Inc (ADMA)
Currently, there are 238.53M common shares owned by the public and among those 230.42M shares have been available to trade. The company’s stock has a 5-day price change of -9.44% and 0.96% over the past three months. ADMA shares are trading 10.15% year to date (YTD), with the 12-month market performance up to 75.23% higher. […]
An Important Check-Up On Adma Biologics Inc (NASDAQ: ADMA)
Adma Biologics Inc (ADMA) concluded trading on Thursday at a closing price of $21.60, with 3.63 million shares of worth about $78.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.62% during that period and on June 12, 2025 the price saw a […]
Adma Biologics Inc (NASDAQ: ADMA) Stock In Prove Me State
Adma Biologics Inc (ADMA) concluded trading on Wednesday at a closing price of $23.61, with 3.78 million shares of worth about $89.27 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 21.89% during that period and on May 07, 2025 the price saw a […]
Adma Biologics Inc (ADMA): Street Finally Waking Up
Currently, there are 236.62M common shares owned by the public and among those 230.23M shares have been available to trade. The company’s stock has a 5-day price change of 24.80% and 51.39% over the past three months. ADMA shares are trading 42.92% year to date (YTD), with the 12-month market performance up to 279.41% higher. […]
Uncovering Institutional Buying In Adma Biologics Inc (NASDAQ: ADMA)
BlackRock Fund Advisors recently announced the acquisition of new stake in Adma Biologics Inc (NASDAQ:ADMA). The institutional investor has increased its shareholding in the Healthcare company by 1.87% to 15.09 million shares with purchase of 0.28 million shares. This fresh investment now brings its stake to 6.68% valued currently at $55.84 million. In addition, The […]
Adma Biologics Inc (NASDAQ: ADMA): Reassessing Prospects
Adma Biologics Inc (ADMA) concluded trading on 12/28/23 at a closing price of $4.52, with 4.18 million shares of worth about $18.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.52% during that period and on Thursday the price saw a gain of […]